0001628280-23-010589.txt : 20230404
0001628280-23-010589.hdr.sgml : 20230404
20230404160959
ACCESSION NUMBER: 0001628280-23-010589
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Almenoff June Sherie
CENTRAL INDEX KEY: 0001492647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 23797463
MAIL ADDRESS:
STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC.
STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wf-form4_168063897592978.xml
FORM 4
X0407
4
2023-03-31
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001492647
Almenoff June Sherie
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
0
Stock Option (Right to Buy)
1.75
2023-03-31
4
A
0
1167
0
A
2023-03-31
2033-03-31
Common Stock
1167.0
1167
D
100% of the stock option will immediately vest on the date that it is granted.
/s/ Jennifer Zoltoski, by Power of Attorney
2023-04-04